Valeritas
Edit

Valeritas

https://www.valeritas.com/
Last activity: 11.03.2021
Categories: ProductMedTechMarketHardwareDrugDevelopmentDeliveryTechnologyWearables
Developing non-electrical basal and bolus drug delivery technologies and devices for large and small molecules. The first product is a basal-bolus insulin pump for the Type II Diabetes market.
Mentions
15
Location: United States, New Jersey, Parsippany-Troy Hills
Total raised: $250M

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
07.06.2013-$100M-
12.09.2011Series C$150M-

Mentions in press and media 15

DateTitleDescriptionSource
26.03.2015Diabetes: Valeritas delays $75m IPOValeritas today postponed its planned initial public offering, which at the midpoint was slated to f...massdevice...
12.03.2015Valeritas sets terms for $75m IPO | Medtech Wall Street news...Diabetes: Valeritas sets terms for $75m IPO March 10, 2015 by Brad Perriello Valeritas yesterday se...massdevice...
10.03.2015Diabetes: Valeritas sets terms for $75m IPOValeritas yesterday set the terms for its forthcoming initial public offering, saying it plans to pu...massdevice...
13.02.2015Diabetes: Valeritas registers $90m IPOValeritas yesterday registered for an initial public offering worth up to $90 million for its V-Go i...massdevice...
07.07.2014Type 2 insulin pump maker Valeritas raising large equity rou...Valeritas raised $100 million in structured debt financing in June 2013 to commercialize the V-Go, b...medcitynew...
16.10.2013Straight Talk About Diabetes: More Tools NeededPreventative measures should actually include bariatric procedures, he added, noting, “The risk redu...medcitynew...
07.06.2013Valeritas Closes $100M Debt Financing with Capital RoyaltyValeritas, Bridgewater, N.J.-based insulin delivery device, closed a $100m structured debt financing...finsmes.co...
04.06.2013Diabetes: Valeritas lands $100M fund for insulin delivery sy...Diabetes devices maker Valeritas announced today that it closed a structured debt financing with $10...massdevice...
09.07.2012B-to-c diabetes patient engagement company adds b-to-b capab...As various healthcare stakeholders look for ways to engage patients in a bid to keep them healthy an...medcitynew...
12.09.2011Valeritas Announces $150M Series C Welsh, Carson, Anderson and Stowe led the financing and assumes a controlling interest in Valerita...vcnewsdail...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In